A new era for autoimmune care: Stem cell and CAR T therapies show remarkable promise

Today, a new approach is giving patients and their physicians reason to hope. Moffitt Cancer Center has expanded its ...
Targeted Oncology

CAR T REMS Elimination Eases Burden on Treatment Centers

Frederick L. Locke, MD, chair in the department of blood and marrow transplant and cellular immunotherapy at Moffitt Cancer ...
The Business Journal

Central Valley hospitals join elite group offering revolutionary CAR-T cancer therapy

Community Health System and Valley Children’s Healthcare are leading the charge in Central Valley cancer treatment, bringing advanced cellular and gene therapies — including CAR-T therapy — closer to ...

New CAR T strategy targets most common form of heart disease

A pioneering preclinical study has shown that CAR T cell therapy—a personalized form of immunotherapy used in cancer ...
Targeted Oncology

Behind the FDA’s Elimination of REMS Program for CAR T-Cell Therapies

In an interview with Targeted Oncology, Frederick L. Locke, MD, discussed how the elimination of the REMS program for CAR T-cell therapy came about and what effects he hopes this will have on patient ...
The American Journal of Managed Care

Expanding CAR T-Cell Access With Broader Criteria and Real-World Data: Clark Alsfeld, MD

At the Institute for Value-Based Medicine ® event in New Orleans, Louisiana, on November 4, Clark Alsfeld, MD, a hematology ...
Medical News Today

What is the best timing for CAR T-cell treatment and more FAQ

CAR T-cell therapy has revolutionized treatment for many blood cancers. However, the benefits of its use in the early stages of care remain uncertain. Chimeric antigen receptor (CAR) T-cell therapy ...